Stockreport

CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01

CalAmp Corp.  (CAMP) 
Last calamp corp. earnings: 12/19 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.calamp.com/home/default.aspx
PDF CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical compan [Read more]